Multiple sclerosis and neuromyelitis optica—two inflammatory demyelinating diseases with different pathogenesis and treatment regimens—have overlapping clinical manifestations, which can make diagnosis at initial presentation difficult. Now, a new guideline aims to improve early treatment decisions in patients with these disorders, particularly in the Asia–Pacific region.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Comi, G. et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357, 1576–1582 (2001).
Carroll, W. M. et al. A guide to facilitate the early treatment in patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica). Mult. Scler. http://dx.doi.org/10.1177/1352458512471092.
Fukazawa, T. et al. Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders. J. Neurol. Sci. 225, 71–78 (2004).
Sellner, J. et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur. J. Neurol. 17, 1019–1032 (2010).
Kim, S. H., Kim, W., Li, X. F., Jung, I. J. & Kim, H. J. Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder? Mult. Scler. 18, 1480–1483 (2012).
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F. & Weinshenker, B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485–1489 (2006).
Morrow, M. J. & Wingerchuk, D. Neuromyelitis optica. J. Neuroophthalmol. 32, 154–166 (2012).
Ratchford, J. N. et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73, 302–308 (2009).
Fazio, R. et al. Antiaquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult. Scler. 15, 1153–1163 (2009).
Kim, J. E. et al. Brain abnormalities in neuromyelitis optica. J. Neurol. Sci. 302, 43–48 (2011).
Acknowledgements
The authors thank M. Freedman, Ottawa Hospital, ON, Canada, for his invaluable comments.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Prayoonwiwat, N., Siritho, S. Early treatment of inflammatory demyelinating disease. Nat Rev Neurol 9, 246–247 (2013). https://doi.org/10.1038/nrneurol.2013.59
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2013.59
